Onesource Specialty Pharma share price
You have to be logged in to add this to Watchlist.- ₹1,586.30(-1.72%)December 16, 2025 15:29:08 PM IST
- NSE
- BSE
- Vol : 65.40 K (NSE + BSE)Last 20 day avg : 180.04 K
Onesource Specialty Pharma is trading -1.72% lower at Rs 1,586.30 as compared to its last closing price. Onesource Specialty Pharma has been trading in the price range of 1,614.65 & 1,585.10. There are 4 analysts who have initiated coverage on Onesource Specialty Pharma. There are 3 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 10.49 Crores in its last quarter.Listed peers of Onesource Specialty Pharma include Torrent Pharmaceuticals (-0.79%), Cipla (-0.48%), Dr Reddy's Laboratories (-0.11%).The Mutual Fund holding in Onesource Specialty Pharma was at 8.99% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Onesource Specialty Pharma was at 19.39% in 30 Sep 2025. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 17, 2025, 12:00 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Neutral | 3,751.05 | -0.79 | 1,26,577.54 | 66.64 | 16.92 | 0.84 | 17.62 |
| Cipla | Bearish | 1,500.00 | -0.48 | 1,21,165.69 | 23.33 | 3.94 | 0.85 | 0.81 |
| Dr Reddy's Laboratories | Bullish | 1,279.00 | -0.11 | 1,06,994.92 | 18.80 | 3.17 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,341.00 | -0.09 | 1,68,204.87 | 78.27 | 11.47 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Neutral | 1,782.80 | -0.80 | 4,28,470.14 | 37.94 | 6.04 | - | - |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-05 | Audited Results |
| 2025-01-29 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE013P01021
- BSE Code544292
- NSE CodeONESOURCE
Onesource Specialty Pharma is trading at 1586.30 as on Tue Dec 16 2025 09:59:08. This is -1.72% lower as compared to its previous closing price of 1614.10.
The market capitalization of Onesource Specialty Pharma is 18176.64 Cr as on Tue Dec 16 2025 09:59:08.
The average broker rating on Onesource Specialty Pharma is Strong Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Onesource Specialty Pharma is 2249.65 whereas the 52 wk low is 1163.05
Onesource Specialty Pharma can be analyzed on the following key metrics -
- TTM P/E: 564.82
- Sector P/E: -
- Dividend Yield: 0.00%
- D/E ratio: 0.22
Onesource Specialty Pharma reported a net profit of -17.97 Cr in 2025.
The Mutual Fund Shareholding was 8.99% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
Onesource Specialty Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.